The Venture Codex Logo

The Venture Codex

Overview

Platform developing intranasal products to combat respiratory viruses.

Total Raised

$361 M

Rounds

6

Links

Verticals

Biotechnology
Life Science
Therapeutics

Investment History

  1. Equity

    Jun 2026

    $45M

  2. Equity

    Oct 2025

    $35M

  3. Debt Financing

    Jun 2025

    $23M

  4. Equity

    Jan 2025

    $70M

  5. Series B

    Jan 2022

    $140M

Team

Koenraad Wiedhaup

CEO and Co-founder

Dinko Valerio

Co-Founder & Executive Chairman

Ronald Brus

Founder and Chief Business Officer

Jaap Goudsmit

Founder and Chief Scientific Officer